Approval · Notice of Compliance 38451 · 2026
JAMP IBUPROFEN: Notice of Compliance 38451
Issued October 9, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38451
- Date
- October 9, 2026
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- APO-IBUPROFEN TAB 600MG (Apotex Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JAMP IBUPROFEN | 02572532 | — |
Medicinal ingredients
- IBUPROFEN 600 MG per TAB